2001

Dec 17, 2001
Guidant Announces Strategic Alliance with HeartCenterOnline

Internet Based Channel Provides Comprehensive Information for Heart Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) today announced a strategic partnership with...

Dec 11, 2001
Guidant Files with FDA for Next-Generation Intravascular Radiotherapy Systemment for High Surgical-Risk Patients

GALILEO III System Designed to Enable Physicians to More Easily and Precisely Treat Longer Heart Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a...

Dec 7, 2001
Guidant's New Defibrillator Manages Abnormal Heart Rates in Upper and Lower Chambers

European Market Release and U.S First Implant of Dual Chamber Defibrillator with Advanced Atrial Arrhythmia Management Indianapolis, Ind. and St. Paul, MN - Guidant Corporation (NYSE and PCX:...

Nov 27, 2001
Guidant Holds Conference Call to Review MADIT II Study

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will conduct a...

Nov 26, 2001
Guidant to Participate In Merrill Lynch Medical Technology Fundamentals Conference

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will...

Nov 20, 2001
Guidant Notified that Landmark Implantable Defibrillator Study Ends Early

MADIT II Study Stopped Due to 30 Percent Mortality Reduction in Heart Attack Survivors with Implantable Defibrillators Indianapolis, IN and St. Paul, MN - The MADIT II investigative team today...

Nov 14, 2001
Guidant Launches Advanced Stent System in Japan

New Technology Offering Provides Significant Benefit to Second Largest Coronary Stent Market in the World Indianapolis, Ind. and Tokyo, Japan. - Guidant Corporation (NYSE and PCX: GDT), a world...

Nov 13, 2001
Guidant Completes Enrollment Of First Drug-Eluting Stent Trial Utilizing Actinomycin-D

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has completed enrollment...

Nov 12, 2001
Results of Guidant's Next Generation Intravascular Radiotherapy System Clinical Trial Revealed

GALILEO INHIBIT Trial Presented Today at American Heart Association Meeting Indianapolis, Ind. and Anaheim, Calif. - The results of Guidant Corporation's (NYSE and PCX: GDT) GALILEO INHIBIT trial...

Nov 12, 2001
Guidant Commends Cook on Promising Results of Latest Paclitaxel-Coated Stent Trial

Indianapolis, Ind. and Anaheim, Calif. - Guidant Corporation (NYSE and PCX: GDT) congratulated Cook Incorporated on the announcement of Cook's highly positive results from its paclitaxel-coated...

Nov 9, 2001
Guidant and Cook Announce FDA Approval To Begin U.S. Clinical Trial With Paclitaxel-Coated Stent

First U.S. Patient Treated in Pivotal Clinical Trial Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) and Cook Incorporated today announced Investigational Device Exemption (IDE)...

Nov 8, 2001
Guidant to Host Vascular Intervention Investor Briefing at AHA

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...

Nov 7, 2001
Guidant and Merck KGaA Collaborate on Heart Failure Education

International Symposium Offers Unique Opportunity for Experts in Device Technology and Drug Therapy to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored...

Nov 6, 2001
Guidant Announces First Human Implant of Newest Active-Fixation Defibrillation Lead

Defibrillation Lead Features Advances in Handling and Visibility for Ease in Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Nov 5, 2001
Guidant's Automated Radiotherapy Treatment for Coronary Artery Disease Receives FDA Approval

GALILEO System Sets New Standards of Precision and Ease of Use Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary...

Oct 18, 2001
Guidant Reports Record Third Quarter Sales of $662 Million

Double Digit Growth from Balanced Geographic Performance; Earnings Per Share Reach $0.40 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment...

Oct 15, 2001
Guidant Announces Live Webcast of Annual Analyst Meetin

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host its annual analyst meeting...

Oct 12, 2001
Guidant Launches Carotid Stent System in Europe

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, today announced that the company has...

Oct 11, 2001
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, will conduct a live webcast of its third quarter 2001 earnings...

Oct 10, 2001
Guidant Announces Worldwide Launch of New Product for Treating Peripheral Vascular Disease

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT) today announced the global launch of its second-generation VIATRAC(tm) 14 PLUS Peripheral Dilatation Catheter...

Oct 9, 2001
Guidant Announces CE Mark Approval and First Implants of Advanced Pacemaker System

New Pacemaker Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 8, 2001
Guidant and Cook Announce Submission of FDA filing to begin U.S. Drug-Coated Stent Trial

Indianapolis, Ind. and Bloomington, Ind. - Guidant Corporation (NYSE and PCX: GDT) and COOK Incorporated today announced that an investigational device exemption (IDE) application has been...

Sep 25, 2001
Guidant Appoints Ralph Hall Deputy General Counsel, Litigation and Compliance

Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced that Ralph Hall, currently secretary and general counsel, cardiac rhythm management, has been promoted...

Sep 21, 2001
Guidant Strengthens Cardiovascular Product Line by Entering New Segment of Guide Wire Market

Company Launches New Polymer Coated Guide Wire in the U.S. Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery...

Sep 19, 2001
Guidant Announces Significant Progress in its Multiple Programs for Drug-Coated Stents

Guidant Completes ACTION Clinical Trial Enrollment for FDA Filing; Company Confirms Submission of PMA Amendment for Heart Failure Technology Guidant Completes ACTION Clinical Trial Enrollment for...

Show per page

Top